TGen and ABL pursue global rollout of advanced TB test

Mar 19, 2019

FLAGSTAFF, Ariz.,LUXEMBOURG City, Luxembourg — In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories (ABL), to market and distribute TGen’s patented and Next Generation Sequencing based TB test technology.